Stay updated on Rituximab in Eosinophilic Granulomatosis Clinical Trial
Sign up to get notified when there's something new on the Rituximab in Eosinophilic Granulomatosis Clinical Trial page.

Latest updates to the Rituximab in Eosinophilic Granulomatosis Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision label updated from v3.5.2 to v3.5.3 on the page. This reflects a minor deployment or content refresh to the study details page.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedRevision: v3.5.2 is now displayed, replacing the previous v3.5.0.SummaryDifference0.1%

- Check47 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check55 days agoChange DetectedThe study record now shows Completed status, the primary completion date, enrollment, and a new 2025 publication summarizing the results.SummaryDifference0.1%

- Check62 days agoChange Detected- Revision: v3.4.3 replaces v3.4.2 as the page framework version.SummaryDifference0.1%

- Check90 days agoChange DetectedAdded Revision: v3.4.2; removed the funding-lapse notice and the previous Revision: v3.4.1 text.SummaryDifference0.4%

Stay in the know with updates to Rituximab in Eosinophilic Granulomatosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rituximab in Eosinophilic Granulomatosis Clinical Trial page.